Vincerx Pharma (VINC) Earnings Date & Reports

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

VINC is expected to report earnings to fall 19.59% to -13 cents per share on April 01

Vincerx Pharma VINC Stock Earnings Reports

Q4'24

Est.

$-0.14

Q3'24

Beat

by $0.05

Q2'24

Beat

by $0.16

Q1'24

Missed

by $0.34

Q4'23

Beat

by $0.14

The last earnings report on November 12 showed earnings per share of -17 cents, beating the estimate of -21 cents. With 225.25K shares outstanding, the current market capitalization sits at 1.29M.

View a ticker or compare two or three

Compare

VINC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For VINC
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a blank check company, which was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, and reorganization

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

260 Sheridan Avenue

Phone

+1 650 800-6676

Employees

Web

https://www.vincerx.com